What is IgniteData?
IgniteData specializes in the seamless and secure integration of patient data for clinical trials via its proprietary technology, Archer. This platform is designed to enable hospitals to transfer clinical data efficiently, thereby reducing errors and enhancing productivity through automated data collection. Archer primarily targets hospitals and clinical trial sponsors, aiming to improve the efficiency of data management by bridging the gap between electronic health records (EHR) and electronic data capture (EDC) systems. Since its inception in 2014, IgniteData has been dedicated to advancing clinical trials by fostering greater interoperability within healthcare data systems.
How much funding has IgniteData raised?
IgniteData has raised a total of $10.9M across 3 funding rounds:
Multiple Rounds
$10.9M
Private Equity (2025): $8.1M, investors not publicly disclosed
Private Equity (2025): $1.1M, investors not publicly disclosed
Private Equity (2025): $1.7M, investors not publicly disclosed
What's next for IgniteData?
The substantial enterprise-level funding IgniteData has garnered, particularly the recent strategic investment, positions the company for accelerated growth and market expansion. This capital injection is expected to fuel further development of its Archer platform, enhance its go-to-market strategies, and solidify its role as a key player in the clinical trial data integration space. The company's focus on modernizing clinical trials through improved data interoperability suggests a trajectory towards broader adoption by healthcare institutions and pharmaceutical companies seeking to streamline their research and development pipelines.
See full IgniteData company page
